A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis
Clinical trial NCT02576678 · COMPLETED
Trial details
- NCT number
- NCT02576678
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-13
- Primary completion
- 2017-09-04
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.